Impact of Adherence to Guideline-Directed Therapy on Risk of Death in HF Patients Across an Ejection Fraction Spectrum
Authors:
Open Access
- 6 October 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 10 (6) , 3656-3666
Abstract
Aims: How different degrees of adherence to guideline-directed medical therapy (GDMT) affect mortality risk in patients with heart failure (HF) in a real-world clinical setting is poorly understood. This study sought to investigate how different levels of adherence to GDMT were associated with the risk of all-cause mortality in patients with HF across a spectrum of left ventricular ejection fractions (LVEFs) in a real-world clinical setting. Methods and results: A total of 64 610 HF patients with no missing value of LVEF from the Swedish Heart Failure Registry were included in the study. Patients were divided according to different LVEFs (<30%, 30–39%, 40–49%, and≥50%) and stratified by an adherence score (good, moderate, or poor) according to the triple, double, and single one usage of GDMT: angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, beta-blockers, and mineralocorticoid receptor antagonists. The outcome is time to all-cause mortality. The mean age of the whole cohort was 73.9 ± 12.1 years, and the proportion of patients in LVEF < 30%, 30–39%, 40–49%, and≥50% groups was 27.6%, 26.9%, 22.1%, and 23.3%, respectively. Patients with LVEF < 30% had the highest mortality rate, almost 20% higher than those with LVEF ≥ 50% {hazard ratio [HR] [95% confidence interval (CI)]: 0.80 [0.71–0.90], P < 0.001}. After treatment of GDMT with good adherence, patients with LVEF < 30% had similar mortality to those with LVEF ≥ 50% [HR (95% CI): 0.97 (0.86–1.10), P = 0.664]. However, the percentage of moderate or poor GDMT was alarmingly high, with good adherence only in 20% of the patients. Conclusions: Good adherence to GDMT works best in patients with LVEF < 50%, whereas moderate adherence to GDMT varies in efficacy depending on the components of the drug combinations.Keywords
Funding Information
- Swedish Heart Lung Foundation (20210247)
- Swedish Association of Local Authorities and Regions
- Sveriges Kommuner och Landsting
This publication has 30 references indexed in Scilit:
- Physicians’ Adherence to Guideline-Recommended Medications in Heart Failure with Reduced Ejection Fraction: Data from the QUALIFY Global SurveyEuropean Journal of Heart Failure, 2016
- Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fractionEuropean Heart Journal, 2015
- Dose matters! Optimisation of guideline adherence is associated with lower mortality in stable patients with chronic heart failureInternational Journal of Cardiology, 2014
- Spironolactone for Heart Failure with Preserved Ejection FractionNew England Journal of Medicine, 2014
- Heart Failure Registry: A Valuable Tool for Improving the Management of Patients with Heart FailureEuropean Journal of Heart Failure, 2009
- Are There Any Significant Differences Between Females and Males in the Management of Heart Failure? Gender Aspects of an Elderly Population With Symptoms Associated With Heart FailureJournal of Cardiac Failure, 2009
- Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: Findings from IMPROVE HFAmerican Heart Journal, 2009
- Irbesartan in Patients with Heart Failure and Preserved Ejection FractionNew England Journal of Medicine, 2008
- Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER surveyEuropean Heart Journal, 2005
- Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved TrialThe Lancet, 2003